Treatment Study of Frozen Shoulder: Corticosteroid Injection in Joint Versus Wait and See Policy (FSS)
Shoulder Capsulitis, Shoulder Adhesive Capsulitis, Frozen Shoulder
About this trial
This is an interventional treatment trial for Shoulder Capsulitis focused on measuring shoulder capsulitis, frozen shoulder, adhesive capsulitis, distension, corticosteroid injection, intraarticular injection
Eligibility Criteria
Inclusion Criteria:
- Patients who on clinical examination show reduced shoulder movements with pain where commonly lateral rotation is most restricted, medial rotation least restricted and abduction is somewhat restricted, somewhere in between the two other movements, is called a capsular pattern of movement confirming shoulder capsulitis
- Had had the condition for at least 2 months
- Reduction of movement is at least 30% of normal in two of the three passive movements
- Are ready to undergo treatment as set up before hand (agree to participate in one of the three groups)
- Agree not to undergo other treatment simultaneously directed at the stiff shoulder other than in the control group
- Patient has voluntarily given his/her written consent for participation
- Has not already received intraarticular corticosteroid injection prior to entry in the study less than 4 weeks earlier
Exclusion Criteria:
- Diabetes, as in some diabetic patients, steroids can disturb the regulation of their blood sugar levels.
- One of the two shoulder movements are normal, either passive abduction or passive lateral rotation
- Have some systemic disease where use of corticosteroids is either contraindicated or affect the coexisting disorder
- Patients with asthma using steroid inhalations or steroids orally
- There are other coexisting disorders in the arm or patient has a painful neck that can disturb pain and functional assessment of the shoulder
- Pregnant and breast feeding mothers
- Patients under 18 years of age
- Patients who do not understand Norwegian
- Patients who have reduced intellectual capacity for consent-giving
Sites / Locations
- Rolland legesenter
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Active Comparator
No Intervention
Steroid injection Without distension
Steroid with distension
Control
Group 1 consists of patients receiving Triamcinolone acetonide 20 mg intraarticular injection with Lidocaine 10mg/ml 3 ml and a total of 4 ml solution.
Patients in group 2 will receive intraarticular Triamcinolone Acetonide 20 mg, 3 ml Lidocaine and physiological natrium chloride 9 mg/ml, comprising a total volume from 8 ml and upwards up to 20 ml
Group 3 will serve as control group and patients in this group could receive any other treatment other than corticosteroid injections or per oral corticosteroid medication. The control group will remain without treatment with corticosteroids, in injection or tablet form till 61 days, which is also the last day of the outcome measurements.